Browser does not support script.
Skip to main content
The 11th annual Britain Against Cancer conference, hosted by the All Party Parliamentary Group on Cancer (APPGC), took place on 1 December in Church House, Westminster.
The conference brought together patients, health professionals and policy makers to look at the impact of public policy on cancer services and research.
John Baron MP
View John Baron's presentation [PDF, 97kb] |
Andy Burnham MP
Through the course of the day, Britain Against Cancer delegates heard responses to the report from the Secretary of State for Health, Andy Burnham MP, the Conservative Shadow Health Minister, Mark Simmonds MP, and the Liberal Democrat Shadow Health Secretary, Norman Lamb, all of whom welcomed the APPGC’s recommendations and took questions from the floor on how cancer inequalities can be tackled. Furthermore, the National Cancer Director, Professor Mike Richards, spoke in an afternoon plenary session to give his assessment of the year.
View Mike Richard's presentation [PDF, 201kb] |
The APPGC will now await the Government’s formal response to the Inquiry report as part of the National Cancer Equality Initiative’s vision document, which is expected to be published at the beginning of 2010. The group will also work throughout next year to encourage the Government to accept the report recommendations and work in partnership with other relevant organisation and agencies to develop a plan for implementation.
Six breakout sessions, lead by experts in their fields, were held through the course of the day, looking at the nature of cancer inequalities and ideas for how to tackle them.
You can find notes and presentations from the speakers on the links below:
Wider access to drug treatments |
Research and technologies |
Public health and prevention |
Rarer cancers |
Awareness and early detection |
The All Party Parliamentary Group on Cancer would like to thank the supporters of the Britain Against Cancer 2009 Conference. All have a medical expertise and commercial interest in cancer, but had no involvement in the programme of the conference:
AstraZeneca, GlaxoSmithKlein, Novartis, Pfizer, Roche, Sanofi-aventis, Sanofi-Pasteur MSD
If you have any questions about Macmillan we would love to hear from you| .
You can also follow us| on Facebook, Twitter, Flickr or YouTube.
© Macmillan Cancer Support 2013
what are these?|